Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ademetionine 1,4 - Butanedisulfonate for injection

Approval Number

国药准字H20213159

Company吉林敖东药业集团延吉股份有限公司

Registration Date

March 9, 2021

Drug Information

Generic Name

注射用丁二磺酸腺苷蛋氨酸

Dosage Form

注射剂

Strength

0.5g(以腺苷蛋氨酸计)

Drug Type

化学药品

Registration Date

March 9, 2021

Company Information

Applicant Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

Manufacturing Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy